Company Filing History:
1 out of 4 
1 out of 3 Years Active: 2025
Title: The Innovative Contributions of Kelly Rhodes
Introduction
Kelly Rhodes is a notable inventor based in Hatfield, PA (US), recognized for her significant contributions to the field of biotechnology. With a focus on cellular delivery systems, she has developed innovative methods that enhance the targeted delivery of active agents to specific cell types. Her work has the potential to revolutionize therapeutic approaches in medicine.
Latest Patents
Rhodes holds a patent for "Cellular delivery of DNA intercalating agents." This patent describes compositions and methods for the targeted delivery of active agents to cells. The compositions consist of a wholly or partially double-stranded synthetic DNA carrier, which intercalates an active agent within its double-stranded portions. Additionally, the DNA carrier can be linked to a targeting agent, making it particularly useful for delivering cytotoxic agents to specific cell types.
Career Highlights
Throughout her career, Kelly Rhodes has worked with prominent organizations such as Code Biotherapeutics, Inc. and the Lankenau Institute of Medical Research. Her experience in these institutions has allowed her to refine her expertise in biotherapeutics and contribute to groundbreaking research in the field.
Collaborations
Rhodes has collaborated with esteemed colleagues, including Robert C. Getts and James Kadushin. These partnerships have fostered an environment of innovation and have led to advancements in her research endeavors.
Conclusion
Kelly Rhodes exemplifies the spirit of innovation in biotechnology through her pioneering work in cellular delivery systems. Her contributions are paving the way for new therapeutic strategies that could significantly impact patient care.